Cambridge Eyenovations


Public lists: Eye Health (701)

Cambridge Eyenovations is developing drug-eluting contact lenses that can dispense medicine automatically for glaucoma patients so that people don't need to put in eyedrops at all, and can go a month without changing contact lenses.

Cambridge Eyenovations is developing drug-eluting contact lenses that can dispense medicine automatically for glaucoma patients so that people don't need to put in eyedrops at all, and can go a month without changing contact lenses.

Company (Alive / Active)

Phone:

Fax:

Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Cambridge Eyenovations $0M May 6, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Cambridge Eyenovations Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Ekos

Bothell, Washington, United States
AcquiredEKOS develops clinical application of ultrasound accelerated thrombolysis for the treatment of vascular thrombosis and dissolution of thrombus.Login to see details

AcelRx Pharmaceuticals

Redwood City, California, United States
IPO / Went publicAcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, Zalviso, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps. A...Show allLogin to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)